newsfilter
← Latest News
Earnings Call Transcripts·

AC IMMUNE - CONFERENCE CALL & LIVE WEBCAST - AC IMMUNE SA

Hello, and a warm welcome to everyone joining this call, where we will discuss the results of part one of the vaccine phase two trial, covering both the 18-month treatment period and the six-month safety follow-up. Today

Company
AC IMMUNE SA
Keywords
AC IMMUNE SA